Scientists probe immune system for clues to beat hepatitis b
NCT ID NCT01796457
Summary
This study aims to understand how the body's immune system changes when people with chronic hepatitis B receive treatment. Researchers will observe 40 adults already enrolled in other hepatitis B treatment trials. By measuring immune cells and signals in blood samples, they hope to learn which immune responses predict a good, long-term outcome from therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
California Pacific Medical Center
San Francisco, California, 94115, United States
-
Harborview Medical Center
Seattle, Washington, 98104, United States
-
Toronto Western Hospital Liver Centre
Toronto, Ontario, Canada
-
University of California San Francisco Medical Center
San Francisco, California, 94143, United States
-
University of Minnesota
Plymouth, Minnesota, 55446, United States
-
Virginia Commonwealth University Medical Center
Richmond, Virginia, 23298, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.